Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy

Metabolism: Clinical and Experimental

Volumn 52, Issue 7, 2003, Pages 916-921

  Hammad, Samar M ^a   Powell Braxton, Lyn ^a   Otvos, James D ^a   Eldridge, Leslie ^a   Won, Wesley ^a   Lyons, Timothy J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; POLYPEPTIDE; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SERUM; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; WILD TYPE;

EID: 0041589508     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00058-1     Document Type: Article

References (30)

1. Pyrala K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: A n epidemiologic view. Diabetes Metab Rev 3:463-524, 1987
2. Bierman EL: George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb 12:647-656, 1992
3. Uusitupa MI, Niskanen LK, Siitonen O, et al: 5-Year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 82:27-36, 1990
4. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Lyons TJ, Jenkins AJ: Glycation, oxidation and lipoxidation in the development of the complications of diabetes mellitus: A "carbonhyl stress" hypothesis. Diabetes Rev 5:365-391, 1997
6. Baynes JW, Thorpe SR: Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708-1716, 2000
7. Gardner CD, Fortmann SP, Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276:875-881, 1996
8. Lamauche B, Tchernof A, Mourjani S, et al: Small, dense, low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study. Circulation 95:69-75, 1997
9. Superko HR: New aspects of risk factors for the development of atherosclerosis, including small dense lipoprotein, homocyst(e)ine, and lipoprotein (a). Curr Opin Cardiol 10:347-354, 1995
10. Eckardstein A, Huang Y, Assmann G: Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol 5:404-416, 1994
11. Otvos J, Jeyarajah E, Bennett D: A spectroscopic approach to lipoprotein subclass analysis. J Clin Ligand Assay 19:184-189, 1996
12. Lyons TJ, Jenkins AJ, Zheng D, et al: Serum lipoproteins in the DCCT/EDIC Cohort: Associations with diabetic retinopathy. Invest Ophthalmol Vis Sci (in revision)
13. Jenkins AJ, Lyons TJ, Zheng D, et al: Serum lipoproteins in the DCCT/EDIC Cohort: Associations with diabetic nephropathy. Kidney Int (in press)
14. Kunjathoor VV, Wilson DL, LeBoeuf RC: Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97:1767-1773, 1996
15. Park L, Raman KG, Lee KJ, et al: Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025-1031, 1998
16. Reaven P, Merat S, Casanada F, et al.: Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 17:2250-2256, 1997
17. Keren P, George J, Shaish A, et al: Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: Establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 49:1064-1069, 2000
18. Powell-Braxton L, Veniant M, Latvala RD, et al: A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med 4:934-938, 1998
19. Nakamuta M, Taniguchi S, Ishida BY, et al: Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: Role of apoB mRNA editing in lipoprotein phenotype expression. Arterioscler Thromb Vasc Biol 18:747-755, 1998
20. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 8:499-502, 1972
21. Otvos JD, Jeyarajah EJ, Bennett DW, et al: Development of a proton nuclear resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 38:1632-1638, 1992
22. Otvos JD: Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectoroscopy. Clin Lab 48:171-180, 2002
23. Redgrave TG, Carlson LA: Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipd Res 20:217-229, 1979
24. Zhang SH, Reddick RL, Piedrahita JA, et al: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471, 1992
25. Ishibashi S, Brown MS, Goldstein JL, et al: Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92:883-893, 1993
26. Jiao S, Cole TG, Kitchens RT, et al: Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography. Metabolism 39:155-160, 1990
27. Tsutsumi K, Hagi A, Inoue Y: The relationship between plasma high density lipoprotein cholesterol levels and cholesteryl ester transfer protein activity in six species of healthy experimental animals. Biol Pharma Bull 24:579-581, 2001
28. Hansen PR: Cholesterol ester transfer protein. A major player in cholesterol metabolism. Ugeskr Laeger 161:5295-5298, 1999
29. Francone OL, Royer L, Haghpassand M: Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. J Lipid Res 37: 1268-1277, 1996
30. Veniant MM, Sullivan MA, Kim SK, et al: Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100. J Clin Invest 106:1501-1510, 2000